The Essential Roles of Chemistry in High-Throughput Screening Triage

Citations Over TimeTop 10% of 2014 papers

Abstract

It is increasingly clear that academic high-throughput screening (HTS) and virtual HTS triage suffers from a lack of scientists trained in the art and science of early drug discovery chemistry. Many recent publications report the discovery of compounds by screening that are most likely artifacts or promiscuous bioactive compounds, and these results are not placed into the context of previous studies. For HTS to be most successful, it is our contention that there must exist an early partnership between biologists and medicinal chemists. Their combined skill sets are necessary to design robust assays and efficient workflows that will weed out assay artifacts, false positives, promiscuous bioactive compounds and intractable screening hits, efforts that ultimately give projects a better chance at identifying truly useful chemical matter. Expertise in medicinal chemistry, cheminformatics and purification sciences (analytical chemistry) can enhance the post-HTS triage process by quickly removing these problematic chemotypes from consideration, while simultaneously prioritizing the more promising chemical matter for follow-up testing. It is only when biologists and chemists collaborate effectively that HTS can manifest its full promise.

Related Papers

• → Hierarchical virtual screening approaches in small molecule drug discovery(2014)154 cited
• → VSFlow: an open-source ligand-based virtual screening tool(2023)14 cited
• → In Silico Discovery and Virtual Screening of Multi-Target Inhibitors for Proteins in Mycobacterium tuberculosis(2012)42 cited
• → Prediction of New Bioactive Molecules of Chemical Compound Using Boosting Ensemble Methods(2017)2 cited
• → VSFlow: an open-source ligand-based virtual screening tool(2022)